Compare Amphastar Pharmaceuticals Inc (AMPH) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

KOLD is trading at $26.96, up 4.25% with a bullish technical signal supported by moving averages. The stock faces resistance at $27-$29 while finding support at $25-$23 levels. Recent natural gas market volatility driven by weather patterns and LNG demand creates trading opportunities for this bearish natural gas ETF. The RSI at 73.40 indicates potential overbought conditions near-term.

As a tactical trading instrument, KOLD offers exposure to inverse natural gas price movements amid heightened energy market volatility. Key catalysts include weather-driven demand shifts and geopolitical developments affecting LNG exports. Risk factors include sudden natural gas price spikes and changing supply-demand dynamics that could pressure the fund's inverse positioning.